API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/breckenridge-announces-final-approval-of-its-anda-for-rivastigmine-transdermal-system-generic-for-exelon-patch-300967378.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203844
https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-rivastigmine-tartrate-approved-in-us-for-alzheimer-1459335510.pdf
http://www.pharma-excipients.ch/2016/02/05/development-of-a-novel-dry-powder-inhalation-formulation-for-the-delivery-of-rivastigmine-hydrogen-tartrate/
http://www.business-standard.com/article/markets/dr-reddy-s-lab-slips-on-recall-of-rivastigmine-tartrate-capsules-from-usa-115082400229_1.html
https://www.pharmacompass.com/pdf/news/orchids-generic-rivastigmine-tartrate.pdf